OpportunityTitle: Innovators in Hemoglobinopathies Academic Career Development Award (K07)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) .
Description: Purpose. The purpose of the NHLBI Innovators in Hemoglobinopathies Academic Career Development Award is to provide support for salary and research costs for up to 4 years for individuals with medical or doctoral degrees in clinical fields who are not fully established investigators and who want to pursue research careers in sickle cell disease and/or the thalassemias. The primary objective of this program is to advance the research career development of clinician scientists who have implemented innovative programs for patients with sickle cell disease and/or the thalassemias but have not been on a research track. These awards will provide support to clinician scientists who would not be eligible for other NHLBI mentored K awards, i.e., K23, K01, K08, or K25 (http://www.nhlbi.nih.gov/funding/training/redbook/newintro.htm). Prospective Candidates are encouraged to contact the NHLBI staff for specific programmatic and budgetary information (see Section VII. Agency Contacts of this FOA). Mechanism of Support. This FOA will utilize the K07 award mechanism. Candidates must commit a minimum of nine person months (75%) effort to activities covered under the award. Funds Available and Anticipated Number of Awards. The NHLBI intends to commit $2.484 million total costs in FY2011 to support meritorious projects solicited through this RFA. The NHLBI expects to award 6 grants for a total of $9,936,000 in funds over the 4-year project period.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;